Aurinia Pharmaceuticals Inc

(NASDAQ:AUPH)

Latest On Aurinia Pharmaceuticals Inc (AUPH):

Date/Time Type Description Signal Details
2023-05-22 04:58 ESTNewsAurinia: Despite Milder Shareholder Vote, A Bid To Sell Is Still Not OverN/A
2023-05-18 03:27 ESTNewsAurinia Pharmaceuticals gains as two board members resign amid holder voteN/A
2023-05-11 16:54 ESTNewsAurinia Pharma's largest holder to oppose seven director nominationsN/A
2023-05-04 22:29 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:27 ESTNewsAurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29MN/A
2023-05-04 09:27 ESTNewsAurinia Pharma gains after Q1 beat and guidance raiseN/A
2023-05-03 21:13 ESTNewsAurinia wins U.K. nod for lupus nephritis therapy LupkynisN/A
2023-05-03 21:13 ESTNewsAurinia Pharma Q1 2023 Earnings PreviewN/A
2023-04-24 15:43 ESTNewsAurinia Pharma shareholder says company should put itself up for saleN/A
2023-04-05 19:20 ESTNewsAurinia's Lupkynis shows promise in 18-month kidney biopsy dataN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals gains amid renewed takeover speculationN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: All In On Lupkynis - A Tough BetN/A
2023-03-24 07:05 ESTNewsAurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock ValueN/A
2023-03-23 15:36 ESTNewsAurinia Pharmaceuticals Has Strong Upside PotentialN/A
2023-03-22 08:08 ESTNewsAurinia Pharmaceuticals' Lupkynis Faces Challenges In Lupus Nephritis MarketN/A
2023-02-28 16:56 ESTNewsAurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlookN/A
2023-02-28 16:56 ESTNewsAurinia stock rises as Q4 loss narrows, Lupkynis revenue grows; reaffirms product outlookN/A
2023-02-28 16:56 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 01:47 ESTNewsAurinia Pharma Q4 2022 Earnings PreviewN/A
2023-01-25 14:02 ESTNewsAurinia adds 11% amid patent wins in the U.S. and EUN/A
2023-01-06 09:17 ESTNewsAurinia Pharmaceuticals guides Q4 revenue above estimatesN/A
2023-01-05 20:19 ESTNewsAurinia Pharmaceuticals: Lupkynis Patent Settlement Removes OverhangN/A
2023-01-05 20:19 ESTNewsAurinia's Patent Dispute Is Over, But Without A Buyout, There's No UpsideN/A
2023-01-04 16:36 ESTNewsAurinia Pharmaceuticals gains amid M&A speculation following patent settlementN/A
2023-01-03 13:05 ESTNewsAurinia shares jump 36% on patent challenge settlement with India's Sun PharmaN/A
2022-12-01 07:15 ESTNewsAurinia's lupus nephritis drug Lupkynis gets approval in UKN/A
2022-11-06 23:23 ESTNewsAurinia: A Commercial Stage Company With Major HeadwindsN/A
2022-11-03 23:28 ESTNewsAurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38MN/A
2022-11-03 23:28 ESTNewsAurinia sheds 22% as lackluster Lupkynis uptake leads to guidance cutN/A
2022-11-03 23:28 ESTNewsAurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 13:46 ESTNewsAurinia Pharma Q3 2022 Earnings PreviewN/A
2022-10-21 20:09 ESTNewsAurinia announces resignations of medical chief and senior research executiveN/A
2022-10-21 20:09 ESTNewsAurinia defended at H.C. Wainwright after key resignationsN/A
2022-09-19 19:15 ESTNewsAurinia Pharmaceuticals wins European approval of Lupkynis for lupusN/A
2022-08-24 17:12 ESTNewsAurinia Pharmaceuticals: The Right Play NowN/A
2022-08-16 04:35 ESTNewsAurinia Pharmaceuticals: Updating My Revenue And Valuation ModelN/A
2022-08-04 23:37 ESTNewsAurinia Pharmaceuticals Inc's (AUPH) CEO Peter Greenleaf on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 08:03 ESTNewsAurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16MN/A
2022-08-04 08:02 ESTNewsAurinia narrows 2Q net loss as Lupkynis sales regain momentumN/A
2022-08-03 17:35 ESTNewsAurinia Pharma Q2 2022 Earnings PreviewN/A
2022-07-26 13:19 ESTNewsPatent challenge on Aurinia's Lupkynis could impact takeover interest near-term - CantorN/A
2022-07-22 12:15 ESTNewsAurinia lupus nephritis drug recommended in EuropeN/A
2022-07-16 02:36 ESTNewsAurinia Pharma tumbles after takeover speculation cools on new exec hires, exec departureN/A
2022-07-04 17:27 ESTNewsA Buyout-Driven Pair Trade: Buy Aurinia, Sell Merck (Or Seagen If You Must)N/A
2022-07-01 19:17 ESTNewsAurinia Pharmaceuticals gains on speculation of Otsuka interestN/A
2022-05-24 14:21 ESTNewsAurinia Pharmaceuticals: Some Red Flags To Consider From Q1 2022 EarningsN/A
2022-05-22 11:59 ESTNewsAurinia: Redemption On Lupkynis Sales And Possible EMA ApprovalN/A
2022-05-20 13:35 ESTNewsAurinia Pharmaceuticals touts long-term benefit of Lupkynis for lupusN/A
2022-05-11 00:20 ESTNewsAurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39MN/A
2022-05-11 00:20 ESTNewsAurinia Pharma in focus despite 1Q revenue beat as Omicron hurts Lupkynis salesN/A

About Aurinia Pharmaceuticals Inc (AUPH):

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

See Advanced Chart

General

  • Name Aurinia Pharmaceuticals Inc
  • Symbol AUPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 294
  • Last Split Factor1:50
  • Last Split Date2013-10-23
  • Fiscal Year EndDecember
  • IPO Date1999-01-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.auriniapharma.com
View More

Valuation

  • Forward PE 1428.57
  • Price/Sales (Trailing 12 Mt.) 33.99
  • Price/Book (Most Recent Quarter) 4.49
  • Enterprise Value Revenue 28.78
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -205%
  • Operating Margin -208%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 50.12 million
  • Earnings Per Share -$0.70
  • Revenue Per Share $0.42
  • Gross Profit -209000
  • Quarterly Earnings Growth 172417.2%
View More

Highlights

  • Market Capitalization 1.72 billion
  • EBITDA -58641000
  • Analyst Target Price $11.5
  • Book Value Per Share $3.22
View More

Share Statistics

  • Shares Outstanding 127.45 million
  • Shares Float 116.02 million
  • % Held by Insiders 978%
  • % Held by Institutions 55.87%
  • Shares Short 5.95 million
  • Shares Short Prior Month 5.44 million
  • Short Ratio 1.21
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.47
  • 52 Week High $18.72
  • 52 Week Low $11.3
  • 50 Day Moving Average 14.98
  • 200 Day Moving Average 14.65
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aurinia Pharmaceuticals Inc (AUPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aurinia Pharmaceuticals Inc (AUPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$50.03 million-$0.05-$0.2075.16%
2020-09-302020-11-10$N/A-$0.28-$0.24-19.15%
2020-06-302020-08-11$N/A-$0.26-$0.23-12.51%
2020-03-312020-05-14$30000-$0.15-$0.2743.93%
2019-12-312020-03-05$29000-$0.78-$0.20-281.79%
2019-09-302019-11-14$230000-$0.21-$0.19-11.52%
2019-06-302019-08-06$29000-$0.17-$0.16-7.59%
2019-03-312019-05-14$30000-$0.14-$0.154.11%
2018-12-312019-03-19$29000-$0.17-$0.16-6.25%
2018-09-302018-11-08$375000-$0.21-$0.18-17.98%
2018-06-302018-08-09$29000-$0.19-$0.14-31.94%
2018-03-312018-05-10$30000-$0.18-$0.16-13.71%
2017-12-312018-03-15$31000-$0.04-$0.1471.77%
2017-09-302017-11-14$29000-$0.16-$0.14-11.11%
2017-06-302017-08-10$329000-$0.03-$0.1376.92%
2017-03-312017-05-15$31000-$0.92-$0.12-693.1%
2016-12-312017-03-09$30000-$0.21-$0.11-85.35%
2016-09-302016-11-04$31000-$0.21-$0.15-42.37%
2016-06-302016-08-05$55000-$0.10-$0.116.28%
2016-03-312016-05-11$57000-$0.13-$0.147.14%
2015-12-312016-03-18$57000-$0.13-$0.143.7%
2015-09-302015-11-13$57000-$0.16-$0.2227.27%
2015-06-302015-08-04$59000-$0.02-$0.2090%
2015-03-312015-05-15$62000-$0.27-$0.14-92.86%
2014-12-312015-03-30$68000-$0.15-$0.12-25%
2014-09-302014-11-12$72000-$0.08
2014-06-302014-08-15$71000-$0.13
2014-03-312014-05-16$67000-$0.24
2013-12-312014-03-28$702249.84$0.11
2013-09-302013-11-22$84384.09-$0.45
2013-06-302013-08-14$83833.48-$0.25
2013-03-312013-05-16$87529.5-$0.20
2012-09-302012-11-14$87549.63-$0.49
2008-12-312009-03-27$585963.18-$2.50-$2.00-25%
2008-09-302008-11-14$2.69 million-$2.00-$2.5020%
2008-06-302008-08-06$553324.85-$2.50-$2.500%
2008-03-312008-05-06$564272.49-$2.50-$4.0037.5%
2007-12-312008-03-18$608006.42-$4.00-$4.5011.11%
2007-09-302007-11-06$554715.08-$3.50-$4.8327.54%
2007-06-302007-08-14$432601.29-$4.50-$4.500%
2007-03-312007-05-09$604253.11-$4.00-$4.7515.79%
2006-12-312007-03-16$759070.25-$4.50-$4.836.83%
2006-09-302006-11-14$519853.01-$4.00-$4.5011.11%
2006-06-302006-08-03$935374.15-$4.00-$4.000%
2006-03-312006-05-15$1.37 million-$3.00-$6.5053.85%
2005-12-312006-03-14$367924.53-$5.50-$4.57-20.35%
2005-09-302005-11-04$262185.16-$4.00-$3.00-33.33%
2005-06-302005-08-09$203998.37-$5.50-$6.5015.38%
2005-03-312005-05-13$317539.07-$5.50-$7.0021.43%
2004-12-312005-03-02$205320.03-$6.50-$6.500%
2004-09-302004-11-10$262261.31-$6.00-$6.000%
2004-06-302004-08-10$255063.77-$3.00-$3.257.69%
2004-03-312004-05-13$468046.12-$2.50-$4.0037.5%
2003-12-312004-03-29$314572.09-$5.50-$3.50-57.14%
2003-09-302003-11-25$306771.14-$4.00-$3.75-6.67%
2003-06-302003-08-25$6.53 million$1.00$3.00-66.67%
2003-03-312003-05-23$215925.35-$4.50-$3.00-50%
2002-12-312003-03-11$206650.98-$3.50-$2.00-75%
2002-09-302002-11-26$4.19 million$3.00$0.00

Aurinia Pharmaceuticals Inc (AUPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aurinia Pharmaceuticals Inc (AUPH) Chart:

Aurinia Pharmaceuticals Inc (AUPH) News:

Below you will find a list of latest news for Aurinia Pharmaceuticals Inc (AUPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aurinia Pharmaceuticals Inc (AUPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 01359.27TRUE00
2024-05-1720CALL0 0615.1TRUE00
2024-05-1732.01CALL0 20214.36TRUE00
2024-05-1741.19CALL0 87269.02TRUE00
2024-05-1750.41CALL148 145849.64TRUE-0.09-0.18
2024-05-1760.05CALL448 286867.78FALSE-0.05-0.5
2024-05-1770.03CALL40 90498.87FALSE-0.02-0.4
2024-05-1780.05CALL0 14400FALSE00
2024-05-1790.07CALL0 20FALSE00
2024-05-17100.05CALL0 120FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-1720PUT0 00FALSE00
2024-05-1730PUT0 00FALSE00
2024-05-1740.1PUT3 65133.22FALSE0.10
2024-05-1750.1PUT87 38444.15FALSE-0.2-0.67
2024-05-1761.1PUT0 3379.33TRUE00
2024-05-1772.04PUT10 35177.63TRUE2.040
2024-05-1780PUT0 0163.15TRUE00
2024-05-1790PUT0 0466.41TRUE00
2024-05-17100PUT0 0180.79TRUE00
2024-06-2110CALL0 0725.44TRUE00
2024-06-2120CALL0 0395.91TRUE00
2024-06-2130CALL0 0310.33TRUE00
2024-06-2141.3CALL0 772.43TRUE00
2024-06-2150.55CALL581 6545.51TRUE-0.15-0.21
2024-06-2160.17CALL113 6456.78FALSE-0.13-0.43
2024-06-2170.15CALL0 660FALSE00
2024-06-2180.04CALL10 273.33FALSE0.040
2024-06-2190CALL0 00FALSE00
2024-06-21100CALL0 00FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120PUT0 00FALSE00
2024-06-2130.07PUT0 100FALSE00
2024-06-2140.02PUT4 1446.35FALSE0.020
2024-06-2150.28PUT4 3650.32FALSE-0.17-0.38
2024-06-2160.9PUT2 245.72TRUE0.90
2024-06-2170PUT0 082.77TRUE00
2024-06-2180PUT0 0148.18TRUE00
2024-06-2190PUT0 0240.04TRUE00
2024-06-21100PUT0 0237.81TRUE00
2024-07-1914.7CALL0 10TRUE00
2024-07-1923.25CALL20 21139.04TRUE3.250
2024-07-1932.05CALL0 0125.38TRUE00
2024-07-1941.5CALL5 589.45TRUE1.50
2024-07-1950.65CALL10693 56057.22TRUE-0.15-0.19
2024-07-1960.25CALL16 194954.16FALSE-0.24-0.49
2024-07-1970.12CALL30 187759.65FALSE-0.13-0.52
2024-07-1980.15CALL0 320467.09FALSE00
2024-07-1990.1CALL85 120885.46FALSE0.10
2024-07-19100.05CALL0 13720FALSE00
2024-07-19110.1CALL0 3740FALSE00
2024-07-19120.05CALL3 255100.24FALSE0.050
2024-07-19130.1CALL0 8990FALSE00
2024-07-19140.05CALL0 1220FALSE00
2024-07-19150.1CALL0 3630FALSE00
2024-07-19160.05CALL0 110FALSE00
2024-07-1910PUT0 00FALSE00
2024-07-1920.05PUT0 100FALSE00
2024-07-1930.13PUT0 50FALSE00
2024-07-1940.2PUT0 1060FALSE00
2024-07-1950.3PUT41 390943.24FALSE-0.27-0.47
2024-07-1960.94PUT13 30943.78TRUE0.940
2024-07-1972.25PUT0 35594.48TRUE00
2024-07-1982.5PUT24 317154.8TRUE2.50
2024-07-1993.7PUT0 77172.19TRUE00
2024-07-19105.01PUT0 732181.31TRUE00
2024-07-19110PUT0 0182.39TRUE00
2024-07-19126.6PUT0 0199.59TRUE00
2024-07-19137PUT0 0227.18TRUE00
2024-07-19140PUT0 0218.95TRUE00
2024-07-19159PUT0 0227.36TRUE00
2024-07-191610.76PUT0 0216.01TRUE00
2024-10-1810CALL0 0442.87TRUE00
2024-10-1823.7CALL0 5201.19TRUE00
2024-10-1832.45CALL0 259.56TRUE00
2024-10-1841.45CALL0 13120.23TRUE00
2024-10-1851CALL254 5962.64TRUE10
2024-10-1860.65CALL206 146064.43FALSE0.650
2024-10-1870.3CALL11 19255.8FALSE0.30
2024-10-1880.4CALL2 17659.18FALSE0.10.33
2024-10-1890.2CALL0 130FALSE00
2024-10-18100.25CALL1 5860.38FALSE0.250
2024-10-18110.29CALL16 3974.88FALSE0.290
2024-10-18120.28CALL0 50FALSE00
2024-10-18130CALL0 00FALSE00
2024-10-18140CALL0 00FALSE00
2024-10-18150CALL0 00FALSE00
2024-10-18160CALL0 00FALSE00
2024-10-1810PUT0 00FALSE00
2024-10-1820.08PUT0 300FALSE00
2024-10-1830.15PUT0 310FALSE00
2024-10-1840.42PUT0 358.39FALSE00
2024-10-1850.6PUT11 8753.82FALSE0.60
2024-10-1861.7PUT0 61182.12TRUE00
2024-10-1872.04PUT10 1358.85TRUE2.040
2024-10-1883.15PUT0 7954.5TRUE00
2024-10-1893.72PUT0 10132.81TRUE00
2024-10-18105.1PUT0 22177.69TRUE00
2024-10-18115.35PUT0 0129.92TRUE00
2024-10-18127PUT0 093.13TRUE00
2024-10-18137.81PUT0 0141.27TRUE00
2024-10-18148.1PUT0 0156.2TRUE00
2024-10-18159.2PUT0 0162.37TRUE00
2024-10-18160PUT0 0159.7TRUE00
2025-01-1720CALL0 0128.22TRUE00
2025-01-1732.35CALL0 12863.53TRUE00
2025-01-1741.85CALL6 1071.6TRUE1.850
2025-01-1751.3CALL105 153767.18TRUE-0.12-0.08
2025-01-1760.85CALL0 640FALSE00
2025-01-1770.9CALL58 87059.44FALSE0.20.29
2025-01-1780.46CALL0 2059.37FALSE00
2025-01-17100.2CALL27 502761.43FALSE-0.1-0.33
2025-01-17120.1CALL5 107061.25FALSE-0.02-0.17
2025-01-17150.05CALL6 66764.1FALSE0.050
2025-01-17170.05CALL0 8540FALSE00
2025-01-17200.05CALL0 30240FALSE00
2025-01-1720PUT0 00FALSE00
2025-01-1730.2PUT3 17571.09FALSE0.20
2025-01-1740PUT0 064.74FALSE00
2025-01-1750.9PUT10 37963.48FALSE0.90
2025-01-1760PUT0 061.18TRUE00
2025-01-1772.1PUT3 424054.32TRUE-0.25-0.11
2025-01-1783.2PUT0 156.97TRUE00
2025-01-17105.1PUT0 28160.45TRUE00
2025-01-17126.7PUT0 406112.84TRUE00
2025-01-17159.8PUT0 1167.37TRUE00
2025-01-171711PUT0 0152.65TRUE00
2025-01-172014PUT0 0164.98TRUE00
2026-01-1632.97CALL0 11877.44TRUE00
2026-01-1652CALL1 8568.71TRUE20
2026-01-1671.4CALL3 7267.19FALSE1.40
2026-01-16100.75CALL41 51661.85FALSE0.750
2026-01-16120.7CALL3 1468.14FALSE0.70
2026-01-16150.45CALL6 26966.49FALSE0.450
2026-01-16170.8CALL0 1310FALSE00
2026-01-16200.56CALL0 1840FALSE00
2026-01-1630.6PUT0 2774.55FALSE00
2026-01-1651.4PUT4 34766.05FALSE1.40
2026-01-1672.9PUT0 123264.53TRUE00
2026-01-16104.9PUT0 3869.82TRUE00
2026-01-16127.1PUT0 4591.12TRUE00
2026-01-16159.9PUT0 0161.15TRUE00
2026-01-161711.17PUT0 0169.06TRUE00
2026-01-16200PUT0 099.9TRUE00

Latest AUPH Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST100$10.135
Jun 13, 2022 7:59 PM EST10$10.135
Jun 13, 2022 7:59 PM EST35$10.14

Aurinia Pharmaceuticals Inc (AUPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506618001065/0000315066-18-001065-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506619000891/0000315066-19-000891-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000031506620000811/0000315066-20-000811-index.htm
2017-05-01SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517001237/0000921895-17-001237-index.htm
2017-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189517002488/0000921895-17-002488-index.htm
2019-01-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000092189519000115/0000921895-19-000115-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000108514620000766/0001085146-20-000766-index.htm
2019-04-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919020260/0001104659-19-020260-index.htm
2019-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919033560/0001104659-19-033560-index.htm
2019-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919063369/0001104659-19-063369-index.htm
2019-12-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070670/0001104659-19-070670-index.htm
2019-12-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919070762/0001104659-19-070762-index.htm
2019-12-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919071472/0001104659-19-071472-index.htm
2019-12-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465919073834/0001104659-19-073834-index.htm
2020-01-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000110465920007143/0001104659-20-007143-index.htm
2020-07-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920086013/0001104659-20-086013-index.htm
2020-10-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600620/000110465920113903/0001104659-20-113903-index.htm
2017-07-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000114036117027184/0001140361-17-027184-index.htm
2017-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001041/0001157523-17-001041-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001103/0001157523-17-001103-index.htm
2017-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001104/0001157523-17-001104-index.htm
2017-05-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001401/0001157523-17-001401-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001558/0001157523-17-001558-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001561/0001157523-17-001561-index.htm
2017-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001643/0001157523-17-001643-index.htm
2017-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001712/0001157523-17-001712-index.htm
2017-06-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001796/0001157523-17-001796-index.htm
2017-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001833/0001157523-17-001833-index.htm
2017-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317001937/0001157523-17-001937-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002350/0001157523-17-002350-index.htm
2017-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002443/0001157523-17-002443-index.htm
2017-09-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002536/0001157523-17-002536-index.htm
2017-10-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317002726/0001157523-17-002726-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752317003100/0001157523-17-003100-index.htm
2018-01-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000022/0001157523-18-000022-index.htm
2018-02-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000271/0001157523-18-000271-index.htm
2018-02-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000404/0001157523-18-000404-index.htm
2018-03-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318000566/0001157523-18-000566-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001088/0001157523-18-001088-index.htm
2018-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001332/0001157523-18-001332-index.htm
2018-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001334/0001157523-18-001334-index.htm
2018-07-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001402/0001157523-18-001402-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001785/0001157523-18-001785-index.htm
2018-09-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318001977/0001157523-18-001977-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752318002387/0001157523-18-002387-index.htm
2019-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000099/0001157523-19-000099-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000428/0001157523-19-000428-index.htm
2019-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000461/0001157523-19-000461-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000601/0001157523-19-000601-index.htm
2019-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000650/0001157523-19-000650-index.htm
2019-04-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000799/0001157523-19-000799-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319000945/0001157523-19-000945-index.htm
2019-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001193/0001157523-19-001193-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001219/0001157523-19-001219-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001334/0001157523-19-001334-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001384/0001157523-19-001384-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001414/0001157523-19-001414-index.htm
2019-06-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001429/0001157523-19-001429-index.htm
2019-06-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001445/0001157523-19-001445-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001535/0001157523-19-001535-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319001723/0001157523-19-001723-index.htm
2019-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002052/0001157523-19-002052-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002143/0001157523-19-002143-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002221/0001157523-19-002221-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002261/0001157523-19-002261-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002270/0001157523-19-002270-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002316/0001157523-19-002316-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752319002335/0001157523-19-002335-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000260/0001157523-20-000260-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000305/0001157523-20-000305-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000339/0001157523-20-000339-index.htm
2020-03-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000352/0001157523-20-000352-index.htm
2020-03-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000361/0001157523-20-000361-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000398/0001157523-20-000398-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000535/0001157523-20-000535-index.htm
2020-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000571/0001157523-20-000571-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000743/0001157523-20-000743-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000804/0001157523-20-000804-index.htm
2020-06-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000849/0001157523-20-000849-index.htm
2020-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000869/0001157523-20-000869-index.htm
2020-06-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000876/0001157523-20-000876-index.htm
2020-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320000921/0001157523-20-000921-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001008/0001157523-20-001008-index.htm
2020-07-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001015/0001157523-20-001015-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001168/0001157523-20-001168-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001232/0001157523-20-001232-index.htm
2020-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001271/0001157523-20-001271-index.htm
2020-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001285/0001157523-20-001285-index.htm
2020-10-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001306/0001157523-20-001306-index.htm
2020-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001337/0001157523-20-001337-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001378/0001157523-20-001378-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000115752320001411/0001157523-20-001411-index.htm
2017-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517169703/0001193125-17-169703-index.htm
2017-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517176713/0001193125-17-176713-index.htm
2017-08-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517254546/0001193125-17-254546-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312517342556/0001193125-17-342556-index.htm
2018-01-04F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518002955/0001193125-18-002955-index.htm
2018-01-04F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312518003036/0001193125-18-003036-index.htm
2018-03-26F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312518096084/0001193125-18-096084-index.htm
2018-04-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518108933/0001193125-18-108933-index.htm
2018-06-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000119312518188267/0001193125-18-188267-index.htm
2018-11-30SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339932/0001193125-18-339932-index.htm
2018-11-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312518339945/0001193125-18-339945-index.htm
2019-09-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244954/0001193125-19-244954-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519244975/0001193125-19-244975-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308631/0001193125-19-308631-index.htm
2019-12-09SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519308641/0001193125-19-308641-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519309672/0001193125-19-309672-index.htm
2019-12-10SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312519310256/0001193125-19-310256-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519312201/0001193125-19-312201-index.htm
2019-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312519316575/0001193125-19-316575-index.htm
2020-05-29F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520155700/0001193125-20-155700-index.htm
2020-05-29F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1600620/000119312520155850/0001193125-20-155850-index.htm
2020-06-17F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1600620/000119312520171378/0001193125-20-171378-index.htm
2020-06-26SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520180928/0001193125-20-180928-index.htm
2020-07-22SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197126/0001193125-20-197126-index.htm
2020-07-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197784/0001193125-20-197784-index.htm
2020-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000119312520197855/0001193125-20-197855-index.htm
2019-09-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390019018908/0001213900-19-018908-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600620/000121390020003597/0001213900-20-003597-index.htm
2018-03-1540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828018003228/0001628280-18-003228-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006544/0001628280-18-006544-index.htm
2018-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006852/0001628280-18-006852-index.htm
2018-05-176-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018006878/0001628280-18-006878-index.htm
2018-08-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018010933/0001628280-18-010933-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828018013983/0001628280-18-013983-index.htm
2019-03-1940-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828019003130/0001628280-19-003130-index.htm
2019-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019006728/0001628280-19-006728-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019007420/0001628280-19-007420-index.htm
2019-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019010124/0001628280-19-010124-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828019011709/0001628280-19-011709-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828019014209/0001628280-19-014209-index.htm
2020-03-0540-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1600620/000162828020003036/0001628280-20-003036-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020005759/0001628280-20-005759-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020007783/0001628280-20-007783-index.htm
2020-06-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600620/000162828020009166/0001628280-20-009166-index.htm
2020-08-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600620/000162828020012430/0001628280-20-012430-index.htm
2018-03-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999518000708/9999999995-18-000708-index.htm
2020-06-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600620/999999999520001488/9999999995-20-001488-index.htm